Chapter 3 – 18F‐Labeled PET‐Tracers for Cardiological Imaging

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/B978-0-444-53086-8.00003-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Myocardial Ischemia: Lack of Coronary Blood Flow or Myocardial Oxygen Supply/Demand Imbalance?

  2016cited by this paper
• The Devil is in the Detail

  2014cited by this paper
• Inflammation in Atherosclerosis

  2012cited by this paper
• On the Mechanism of Noradrenaline Depletion by α‐Methyl Metatyrosine and Metaraminol

  2009cited by this paper
• Assessment of Severity of Coronary Artery Stenosis in a Canine Model Using the PET Agent 18F-Fluorobenzyl Triphenyl Phosphonium: Comparison with 99mTc-Tetrofosmin

  2007cited by this paper
• Cardiac denervation in patients with Parkinson disease.

  2007cited by this paper
• Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1.

  2007cited by this paper
• Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.

  2007cited by this paper
• Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp 175Asn mutation in the α-tropomyosin gene: A positron emission tomography study

  2007cited by this paper
• A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metalloproteinase activity in vivo.

  2007cited by this paper
• Cardiac sympathetic denervation preceding motor signs in Parkinson disease

  2007cited by this paper
• Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation

  2007cited by this paper
• Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia.

  2007cited by this paper
• (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

  2007cited by this paper
• The endothelin system and its antagonism in chronic kidney disease.

  2006cited by this paper
• In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.

  2006cited by this paper
• Planar chromatographic analysis and quantification of short-lived radioactive metabolites from microdialysis fractions.

  2006cited by this paper
• Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

  2006cited by this paper
• Imaging Beta-Adrenoceptors in the Human Brain with (5)-l'-[18F]Fluorocarazolol

  2006cited by this paper
• Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium.

  2006cited by this paper
• Why does the agonist [18F]FP-TZTP bind preferentially to the M2 muscarinic receptor?

  2006cited by this paper
• University of Groningen Characterization of pulmonary and myocardial beta-adrenoceptors with S-1'-[fluorine- 18]fluorocarazolol Visser,

  2006cited by this paper
• Imaging Endothelin ETB Receptors Using [18F]-BQ3020: In Vitro Characterization and Positron Emission Tomography (MicroPET)

  2006cited by this paper
• Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept.

  2006cited by this paper
• Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids.

  2006cited by this paper
• Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.

  2006cited by this paper
• The Effect of Insulin on the Intracellular Distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic Acid in Rats

  2006cited by this paper
• 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries

  2006cited by this paper
• Synthesis of an 18F-labelled high affinity β1-adrenoceptor PET radioligand based on ICI 89,406

  2006cited by this paper
• Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.

  2005cited by this paper
• Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging.

  2005cited by this paper
• Positron emission tomography using 18F‐labelled endothelin‐1 reveals prevention of binding to cardiac receptors owing to tissue‐specific clearance by ETB receptors in vivo

  2005cited by this paper
• Neurocirculatory Abnormalities in Parkinson Disease With Orthostatic Hypotension: Independence From Levodopa Treatment

  2005cited by this paper
• Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy

  2005cited by this paper
• [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.

  2005cited by this paper
• Pathophysiology of Coronary Artery Disease

  2005cited by this paper
• Non-invasive molecular imaging of beta-adrenoceptors in vivo: perspectives for PET-radioligands.

  2005cited by this paper
• Physiology and Pharmacology of Temperature Regulation Endothelin – an emerging role in proinflammatory pathways in brain

  2005cited by this paper
• Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis

  2005cited by this paper
• Partial cardiac sympathetic denervation after bilateral thoracic sympathectomy in humans.

  2005cited by this paper
• Identification of Culprit Lesions After Transient Ischemic Attack by Combined 18F Fluorodeoxyglucose Positron-Emission Tomography and High-Resolution Magnetic Resonance Imaging

  2005cited by this paper
• Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography

  2005cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Autonomic receptor systems in the failing and aging human heart: similarities and differences.

  2004cited by this paper
• Cardiac Uptake-1 Inhibition by High Circulating Norepinephrine Levels in Patients with Pheochromocytoma

  2004cited by this paper
• A Potential Cholinergic Mechanism of Procaine's Limbic Activation*

  2004cited by this paper
• Scintigraphic Imaging of Matrix Metalloproteinase Activity in the Arterial Wall In Vivo

  2004cited by this paper
• A novel electrophilic synthesis and evaluation of medium specific radioactivity (1R,2S)-4-[18F]fluorometaraminol, a tracer for the assessment of cardiac sympathetic nerve integrity with PET.

  2004cited by this paper
• (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study.

  2004cited by this paper
• Pharmacological characterisation of novel alpha 2-adrenoceptor antagonists as potential brain imaging agents.

  2004cited by this paper
• In Vivo Imaging of Cardiovascular Endothelin Receptors Using the Novel Radiolabelled Antagonist [18F]-SB209670 and Positron Emission Tomography (microPET)

  2004cited by this paper
• Kinetic analysis of 18F-fluorodihydrorotenone as a deposited myocardial flow tracer: comparison to 201Tl.

  2004cited by this paper
• Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.

  2004cited by this paper
• Receptor imaging in the thorax with PET.

  2004cited by this paper
• Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor.

  2003cited by this paper
• Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque.

  2003cited by this paper
• ETA and ETB receptor function in pancreatitis-associated microcirculatory failure, inflammation, and parenchymal injury.

  2003cited by this paper
• Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.

  2003cited by this paper
• Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lung.

  2003cited by this paper
• Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice.

  2003cited by this paper
• The endothelin axis: emerging role in cancer

  2003cited by this paper
• Aging-related changes in cardiac sympathetic function in humans, assessed by 6-18F-fluorodopamine PET scanning.

  2003cited by this paper
• Radioligands for imaging myocardial α- and β-adrenoceptors

  2003cited by this paper
• 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors.

  2002cited by this paper
• (18)F-Endothelin-1, a positron emission tomography (PET) radioligand for the endothelin receptor system: radiosynthesis and in vivo imaging using microPET.

  2002cited by this paper
• Synthesis and evaluation of (S)-[18F]-fluoroethylcarazolol for in vivo beta-adrenoceptor imaging in the brain.

  2002cited by this paper
• Synthesis of MMP inhibitor radiotracers [11C]methyl-CGS 27023A and its analogs, new potential PET breast cancer imaging agents

  2002cited by this paper
• Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique

  2002cited by this paper
• Classification of endothelin receptors and antagonists in clinical development.

  2002cited by this paper
• Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathy

  2002cited by this paper
• Imaging of pheochromocytoma in 2 dogs using p-[18F] fluorobenzylguanidine.

  2002cited by this paper
• Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET.

  2002cited by this paper
• Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography

  2002cited by this paper
• Design and synthesis of fluorine‐18 labeled matrix metalloproteinase inhibitors for cancer imaging

  2002cited by this paper
• Relative uptake, metabolism, and beta-receptor binding of (1R,2S)-4-(18)F-fluorometaraminol and (123)I-MIBG in normotensive and spontaneously hypertensive rats.

  2002cited by this paper
• PET and SPET tracers for mapping the cardiac nervous system

  2002cited by this paper
• Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy

  2001cited by this paper
• Alpha-adrenoceptor subtypes.

  2001cited by this paper
• An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.

  2001cited by this paper
• Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG)

  2001cited by this paper
• MMP Inhibitor radiotracer [11C]methyl‐CGS 27023A: A new pet breast cancer imaging agent

  2001cited by this paper
• Cardiac neurotransmission imaging.

  2001cited by this paper
• Synthesis and properties of 18F-labeled potential myocardial blood flow tracers.

  2001cited by this paper
• Muscarinic receptors in the mammalian heart.

  2001cited by this paper
• Synthesis and evaluation of radiolabelled antagonists for beta-adrenoceptor imaging in the brain with pet

  2001cited by this paper
• Synthesis of high-specific-radioactivity 4- and 6-[18F]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart.

  2001cited by this paper
• Acetylcholinesterase Inhibition Increases in Vivo N-(2-[18F]Fluoroethyl)-4-piperidyl Benzilate Binding to Muscarinic Acetylcholine Receptors

  2001cited by this paper
• [18F]‐labeled β1‐selective ligands for imaging the adrendergic receptors of the heart

  2001cited by this paper
• Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy.

  2000cited by this paper
• Chemical neuroanatomy of the vesicular amine transporters

  2000cited by this paper
• Cardiac Sympathetic Denervation in Parkinson Disease

  2000cited by this paper
• Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics.

  2000cited by this paper
• Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation.

  2000cited by this paper
• Synthesis, 18F-Labeling, and Biological Evaluation of Piperidyl and Pyrrolidyl Benzilates as in Vivo Ligands for Muscarinic Acetylcholine Receptors

  2000cited by this paper
• β-Adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of β1-adrenoceptor density

  2000cited by this paper
• Syntheses of the first endothelin-A- and -B-selective radioligands for positron emission tomography.

  2000cited by this paper
• Structural studies of matrix metalloproteinases

  2000cited by this paper
• High specific radioactivity (1R,2S)-4-[(18)F]fluorometaraminol: a PET radiotracer for mapping sympathetic nerves of the heart.

  2000cited by this paper
• Dichloroacetate improves postischemic function of hypertrophied rat hearts.

  2000cited by this paper
• Mutagenic activity of a fluorinated analog of the beta-adrenoceptor ligand carazolol in the Ames test.

  2000cited by this paper

• No citing papers are available for this paper.